F021201 | ATP synthesis

Compound Dose Time Species Model Method Action Result Positive criterion Reference
Melittin 5μM and 16μM bovine bovine heart MF1-ATPase Positive IC50 170
Enterostatin Positive 170
ethyldimethylaminopropyl carbodiimide 13 mol of EDC/mol F1 (EF1-ATPase) Positive 95% inhibition 170
1,5-difluoro-2,4-dinitrobenzene Positive 170
NBD-Cl Positive 170
lumiracoxib Positive 197
buformin 62.5 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive p < 0.001 15
buformin 62.5 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive p < 0.001 15
Phenformin 62.5 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive p < 0.001 15
Phenformin 62.5 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive p < 0.001 15
Metformin 657 μM 24 hours human hepatocytes Assay of Cellular ATP Content decrease Positive IC50 15
buformin 26.1 μM 24 hours human hepatocytes Assay of Cellular ATP Content decrease Positive IC50 15
Phenformin 11.7 μM 24 hours human hepatocytes Assay of Cellular ATP Content decrease Positive IC50 15
Metformin 1430 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
buformin 43.7 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
Phenformin 12.9 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
Metformin > 2000 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
buformin > 500 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
Phenformin > 500 μM 24 hours human HepG2 cells Assay of Cellular ATP Content decrease Positive IC50 15
Diclofenac 250 μmol/L 24 hours rat hepatocytes Assay of Cellular ATP contents; Assay of LDH leakage decrease Positive p < 0.01 6
Diclofenac 500 μmol/L 24 hours rat hepatocytes Assay of Cellular ATP contents; Assay of LDH leakage decrease Positive p < 0.01 6